Health
Clinical efficacy and safety of neratinib for breast cancer | DDDT – Dove Medical Press
Clinical efficacy & safety of neratinib for the treatment of adult patients with advanced or metastatic HER2 positive breast…
Introduction
Breast cancer is the most common malignancy in women (approximately 30% of total), where it represents the first cause of cancer-related death.1
From a biological point of view, breast cancer can be classified into molecularly defined subtypes,…
Continue Reading
-
General18 hours agoMatildas vs Panama international friendly — live blog and scores from Bunbury
-
Noosa News23 hours agoAustralia’s biggest sheep drive, and the young drover history forgot
-
Noosa News20 hours agoSearch for man who ‘faked death’ slowed by unusual French law
-
Noosa News19 hours agoPolice appeal for information after two men found dead